Fisher Asset Management LLC raised its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report) by 44.2% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 6,116 shares of the company’s stock after purchasing an additional 1,876 shares during the quarter. Fisher Asset Management LLC’s holdings in GE HealthCare Technologies were worth $473,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds also recently modified their holdings of the company. Raymond James Financial Services Advisors Inc. boosted its holdings in GE HealthCare Technologies by 12.5% during the 3rd quarter. Raymond James Financial Services Advisors Inc. now owns 83,176 shares of the company’s stock worth $5,659,000 after acquiring an additional 9,214 shares during the last quarter. Mackenzie Financial Corp lifted its position in shares of GE HealthCare Technologies by 61.0% during the third quarter. Mackenzie Financial Corp now owns 79,989 shares of the company’s stock valued at $5,358,000 after purchasing an additional 30,301 shares in the last quarter. TD Asset Management Inc boosted its holdings in GE HealthCare Technologies by 2.7% during the third quarter. TD Asset Management Inc now owns 236,830 shares of the company’s stock worth $16,114,000 after purchasing an additional 6,229 shares during the last quarter. TIAA Trust National Association bought a new stake in GE HealthCare Technologies in the 3rd quarter worth about $759,000. Finally, ING Groep NV purchased a new stake in GE HealthCare Technologies in the 3rd quarter valued at about $222,000. Hedge funds and other institutional investors own 82.06% of the company’s stock.
Insider Buying and Selling
In other GE HealthCare Technologies news, insider Frank R. Jimenez purchased 1,315 shares of the company’s stock in a transaction dated Wednesday, May 1st. The stock was purchased at an average price of $76.52 per share, for a total transaction of $100,623.80. Following the transaction, the insider now owns 75,796 shares in the company, valued at approximately $5,799,909.92. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. 0.27% of the stock is currently owned by company insiders.
Analyst Ratings Changes
A number of analysts recently commented on GEHC shares. Bank of America dropped their price target on GE HealthCare Technologies from $94.00 to $86.00 and set a “neutral” rating on the stock in a report on Wednesday, May 1st. Morgan Stanley increased their price target on shares of GE HealthCare Technologies from $74.00 to $86.00 and gave the company an “equal weight” rating in a research report on Monday, February 12th. Evercore ISI lifted their price objective on shares of GE HealthCare Technologies from $93.00 to $100.00 and gave the stock an “outperform” rating in a research report on Thursday, April 4th. Argus increased their target price on shares of GE HealthCare Technologies from $80.00 to $110.00 and gave the company a “buy” rating in a research report on Monday, April 1st. Finally, Mizuho dropped their price objective on GE HealthCare Technologies from $110.00 to $105.00 and set a “buy” rating on the stock in a research note on Wednesday, May 1st. Four research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $95.00.
Read Our Latest Research Report on GEHC
GE HealthCare Technologies Stock Performance
Shares of GEHC opened at $83.40 on Friday. GE HealthCare Technologies Inc. has a 52-week low of $62.35 and a 52-week high of $94.50. The stock’s 50-day simple moving average is $87.22 and its 200 day simple moving average is $79.47. The company has a debt-to-equity ratio of 1.11, a quick ratio of 0.83 and a current ratio of 1.06. The stock has a market capitalization of $38.07 billion, a price-to-earnings ratio of 24.39, a price-to-earnings-growth ratio of 2.87 and a beta of 1.26.
GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) last released its quarterly earnings data on Tuesday, April 30th. The company reported $0.90 EPS for the quarter, meeting analysts’ consensus estimates of $0.90. The company had revenue of $4.65 billion during the quarter, compared to analyst estimates of $4.80 billion. GE HealthCare Technologies had a net margin of 8.05% and a return on equity of 25.32%. GE HealthCare Technologies’s revenue was down 1.2% compared to the same quarter last year. During the same period last year, the business earned $0.85 earnings per share. Research analysts forecast that GE HealthCare Technologies Inc. will post 4.27 EPS for the current fiscal year.
GE HealthCare Technologies Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Friday, April 19th will be issued a $0.03 dividend. The ex-dividend date is Thursday, April 18th. This represents a $0.12 annualized dividend and a dividend yield of 0.14%. GE HealthCare Technologies’s payout ratio is currently 3.51%.
GE HealthCare Technologies Company Profile
(Free Report)
GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.
See Also
Want to see what other hedge funds are holding GEHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report).
Receive News & Ratings for GE HealthCare Technologies Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for GE HealthCare Technologies and related companies with MarketBeat.com’s FREE daily email newsletter.
link